Detalhe da pesquisa
1.
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals.
J Eur Acad Dermatol Venereol
; 37(4): e451-e455, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36469002
2.
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review.
Clin Cosmet Investig Dermatol
; 17: 593-604, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38495913
3.
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study.
Dermatol Reports
; 15(3): 9692, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790655
4.
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study.
Dermatol Ther (Heidelb)
; 12(10): 2309-2324, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063283
5.
Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases.
Dermatol Pract Concept
; 13(2)2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196292
6.
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa.
J Dermatolog Treat
; 34(1): 2256905, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705359
7.
Real-Life Safety and Effectiveness of Dupilumab in Patients with Concomitant Malignancies: a Case Series.
Dermatol Pract Concept
; 13(3)2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37557123
8.
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study.
J Dermatolog Treat
; 34(1): 2200867, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026618
9.
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience.
J Dermatolog Treat
; 34(1): 2216815, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246920
10.
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study.
J Dermatolog Treat
; 34(1): 2241585, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37501617